Status:
COMPLETED
Intravenous Streptokinase in Acute Myocardial Infarction
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Coronary Disease
Eligibility:
All Genders
18-74 years
Phase:
PHASE3
Brief Summary
To determine whether the administration of intravenous streptokinase (SK) early in the course of acute, transmural myocardial infarction would limit myocardial damage.
Detailed Description
BACKGROUND: Determination of the potential value of thrombolytic therapy in patients with acute myocardial infarction was an issue of major importance in 1983. An estimated 1.4 million heart attacks ...
Eligibility Criteria
Men and women, aged less than 75. Myocardial infarction onset within six hours.
Key Trial Info
Start Date :
August 1 1983
Trial Type :
INTERVENTIONAL
End Date :
October 1 1994
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000507
Start Date
August 1 1983
End Date
October 1 1994
Last Update
February 10 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.